ProfileGDS2971 / 11.2.8.5
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 76% 37% 45% 27% 73% 61% 9% 69% 55% 34% 14% 5% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)0.58303876
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.11918737
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.051075845
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.37104827
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.31607873
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.11672261
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)-1.036019
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)0.32947669
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.11353755
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.21619234
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.83024914
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-2.625525